These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 396067)

  • 21. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
    McGrath BP; Matthews PG; Johnston CI
    Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 25. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pressor and adrenal responses to angiotensin II in patients with normoreninemic essential hypertension--the influence of sodium intake and captopril].
    Kuroda K; Ito K; Sakaguchi A; Kimura G; Uda M; Kojima S; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):179-88. PubMed ID: 6353007
    [No Abstract]   [Full Text] [Related]  

  • 29. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1984 Sep; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract]   [Full Text] [Related]  

  • 31. [Captopril in the treatment of hypertension (author's transl)].
    Favre L
    Schweiz Rundsch Med Prax; 1981 Aug; 70(35):1487-90. PubMed ID: 7024978
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 34. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J; Lijnen P; Fagard R; Verschueren LJ; Amery A
    J Endocrinol; 1981 Dec; 91(3):457-65. PubMed ID: 7035596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of blood pressure by the renin-angiotensin system in normal man.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Nature; 1981 May; 291(5813):329-31. PubMed ID: 7015149
    [No Abstract]   [Full Text] [Related]  

  • 36. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
    Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 38. Captopril withdrawal after chronic therapy.
    Vlasses PH; Koffer H; Ferguson RK; Green PJ; McElwain GE
    Clin Exp Hypertens (1978); 1981; 3(5):929-37. PubMed ID: 7026198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium intake and renal responses to captopril in normal man and in essential hypertension.
    Hollenberg NK; Meggs LG; Williams GH; Katz J; Garnic JD; Harrington DP
    Kidney Int; 1981 Aug; 20(2):240-5. PubMed ID: 7026873
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP; Matthews PG; Johnston CI
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.